<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":958,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Holmes v. Merck & Co., 697 F.3d 1080 (9th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/9ed54d21bd784edb8594de6321310895'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/9ed54d21bd784edb8594de6321310895'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1IGTF8003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1IGTF8003">Previous Result: <span>Calderon v. King Umberto, Inc., 892 F. S...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1Q6MEOIPVO2?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1Q6MEOIPVO2">Next Result: <span>Martinez v. Muller, No. 12-1731 (JLL), 2...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='Holmes v. Merck &amp; Co., 697 F.3d 1080 (9th Cir. 2012), Court Opinion'>
Holmes v. Merck &amp; Co., 697 F.3d 1080 (9th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Holmes v. Merck & Co., 697 F.3d 1080 (9th Cir. 2012), Court Opinion</div>
<div class='docId'>X1IGRMK003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Holmes v. Merck & Co.</div>
<div class='displayCitation'>2012 BL 244444</div>
<div class='displayCitation'>697 F.3d 1080</div>
<div class='displayCitation'>wkf9case:26490730</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1IGRMK003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Holmes v. Merck &amp; Co., 697 F.3d 1080 (9th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Holmes v. Merck &amp; Co." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1IGRMK003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1IGRMK003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1IGRMK003" /><input id="title" name="title" type="hidden" value="Holmes v. Merck &amp; Co., 697 F.3d 1080 (9th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="9ed54d21bd784edb8594de6321310895" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1IGRMK003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%39ed%35%34d%32%31bd%37%38%34edb%38%35%39%34de%36%33%32%31%33%31%30%38%39%35%2Fdocument%2FX%31IGRMK%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/bcite/X1IGRMK003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/bcite/X1IGRMK003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/bcite/X1IGRMK003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/related_content/X1IGRMK003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1736096481283";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">697 F.3d 1080</div>
<div class="cite" data-cite-type="DocketNumber">08-16557</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 244444</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Ninth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
Erin HOLMES; Shawn Holmes, Plaintiffs-Appellants, v. MERCK &amp; CO., INC.,
Defendant-Appellee.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 08-16557.
</center></p>
<p><center>
Argued and Submitted December 3, 2009.
</center></p>
<p><center>
Resubmitted April 1, 2011. Filed September 25, 2012.
<span CLASS="page_no" data-cite="697 f 3d 1081" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1081" data-primary-citation="697 F.3d 1080">[*1081]</span> </center></p>
<div id="para2" printdualcolumn="true"><p>

Eckly M. Keach and Robert E. Murdock, Las Vegas, NV, for the appellants.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Denise Barton, Las Vegas, NV, and Donald F. Zimmer, San Francisco, CA, for
the appellees.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the District of Nevada,
Brian E. Sandoval, District Judge, Presiding. D.C. No.
2:04-cv-00608-BES-GWF.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before: BETTY B. FLETCHER, SIDNEY R. THOMAS, and N. RANDY SMITH, Circuit
Judges.
</p></div>
<div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>OPINION</b>
</p></div></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  THOMAS, Circuit Judge:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Erin and Shawn Holmes appeal the district court's grant of summary
judgment in favor of Merck &amp; Company in their diversity action alleging
wrongful death. They contend that the district court erred in applying the
standards of the National Childhood Vaccine Injury Act (Vaccine Act or the
Act), <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20usc%20300aa-22&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-22</a>, to their individual claims for damages. We have
jurisdiction pursuant to <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEIMU8003?jcsearch=28%20usc%201291&amp;summary=yes#jcite">28 U.S.C. &sect; 1291</a>. We affirm.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  When Jacob Holmes was one year old, his pediatrician administered M-M-R
II,<a HREF="#fn100" name="fnref_fn100">[fn1]</a> a vaccine manufactured and distributed by Merck, in conformity with
the recommendations set by the Centers for Disease Control and Prevention.
Within nine days, Jacob began experiencing seizures and developed
encephalopathies. He died approximately six months later.<a HREF="#fn200" name="fnref_fn200">[fn2]</a> Acting on
behalf of their son Jacob's estate, Erin and Shawn Holmes petitioned for
compensation from a government fund created by the Vaccine Act. They
received $250,000 through the program.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Subsequently, acting in their individual capacity and pursuant to Nevada
Revised Statute section <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XJ696U003?jcsearch=Nev.%20Rev.%20Stat.%20%2041.085&amp;summary=yes#jcite">41.085</a>, the Holmes initiated this wrongful death
lawsuit in Clark County, Nevada.<a HREF="#fn300" name="fnref_fn300">[fn3]</a> Their complaint set forth allegations
of negligence, strict product
<span CLASS="page_no" data-cite="697 f 3d 1082" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1082" data-primary-citation="697 F.3d 1080">[*1082]</span> 
liability, negligent design, failure to warn, misrepresentation, express
warranty, implied warranty of merchantability, implied warranty of fitness
for a particular purpose, and punitive damages. Merck removed the case to
the United States District Court for the District of Nevada.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After three years of discovery, Merck filed a motion for summary judgment,
arguing, as is relevant here, that the Vaccine Act foreclosed Plaintiffs'
lawsuit. The district court only partially agreed, holding that the Act
limited Plaintiffs' strict liability and negligence claims to the extent
that the claims relied on allegations of design defect and failure to warn.
But the district court disagreed with Merck's assertion that the Vaccine Act
limited Plaintiffs' other state law claims. The district court therefore
granted in part and denied in part Merck's summary judgment motion and
requested supplemental briefing on Plaintiffs' claims of misrepresentation,
breach of warranty, and punitive damages. Following supplemental briefing on
these remaining state law claims, the district court granted Merck summary
judgment. Plaintiffs then filed <span CLASS="page_no" data-cite="2012 bl 244444 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> a timely appeal to this court, challenging
only the district court's application of <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> of the Vaccine Act to
their design defect and failure to warn claims. After oral argument, we
deferred submission of the case to await the Supreme Court's decision in
<i>Bruesewitz v. Wyeth</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20S.%20Ct.%201068&amp;summary=yes#jcite">562 U.S. ___</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. 1068</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=179%20l%20ed%202d%201&amp;summary=yes#jcite">179 L.Ed.2d 1</a> (2011).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We review de novo a district court's decision to grant summary judgment.
<i>See, e.g., Universal Health Servs., Inc. v. Thompson</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1062OQ003?jcsearch=363%20f%203d%201013&amp;summary=yes#jcite">363 F.3d 1013</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1062OQ003?jcsearch=363%20f%203d%201013&amp;summary=yes#jcite">1019</a>
(9th Cir.2004). We also review de novo a district court's interpretation and
construction of a federal statute. <i>Lively v. Wild Oats Mkts., Inc.</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X15EC10003?jcsearch=456%20f%203d%20933&amp;summary=yes#jcite">456 F.3d 933</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X15EC10003?jcsearch=456%20f%203d%20933&amp;summary=yes#jcite">938</a> (9th Cir.2006).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  II
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The question in this appeal is whether the National Childhood Vaccine
Injury Act preempts all or part of the Plaintiffs' claims. The National
Childhood Vaccine Injury Act is part of the federal government's larger
program of approving, regulating, and promoting vaccines. <i>See</i> National
Childhood Vaccine Injury Act of 1986, Pub. L. No. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=Pub.%20L.%20No.%2099-660&amp;summary=yes#jcite">99-660</a>, Tit. Ill,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=100%20stat%203743&amp;summary=yes#jcite">100 Stat. 3743</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=100%20Stat.%203743&amp;summary=yes#jcite">3756-3784</a> (codified as amended at 42 U.S.C. &sect; 300aa-l <i>et</i>
<i>seq.</i>). The Act arose out of an attempt to balance the need for widespread
childhood vaccinations with the need for "optimal prevention against adverse
reactions to vaccines." 42 U.S.C. &sect; 300aa-l. Congress passed the law after
hearing testimony that, although vaccines inevitably harmed only a very
small number of people, litigation arising from these injuries was
threatening the stability of the nation's vaccine program. <i>See</i> H.R.Rep. No.
99-908, at 4-7 (1986), <i>reprinted in</i>1986 U.S.C.C.A.N. 6344, 6345-48. In
particular, injured persons complained about the tort law system's uncertain
and inequitable recoveries, while vaccine manufacturers testified that the
high cost of litigation was causing insurance premiums to rise and reducing
the number of manufacturers willing to sell childhood vaccines. <i>See </i><cite>id. at
6-7</cite>; <i>see also Bruesewitz</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1072-74</a> (describing impetus behind
Vaccine Act's creation).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Congress addressed these concerns by establishing a "no fault" national
vaccine injury compensation program through which vaccine-injured persons
might quickly and easily obtain damage awards from a "Vaccine Court." <i>See</i>
<i>Schqfer v. Am. Cyanamid Co.</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">20 F.3d 1</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">2</a> (1st Cir.1994) (describing
compensation system and coining "Vaccine Court" term).
<span CLASS="page_no" data-cite="697 f 3d 1083" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1083" data-primary-citation="697 F.3d 1080">[*1083]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Part II of the Act set forth the parameters of this compensation scheme
and instituted a "Vaccine Injury Table" to cover the vaccines and injuries,
for which individuals could seek compensation.<a HREF="#fn400" name="fnref_fn400">[fn4]</a><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EK003?jcsearch=42%20usc%20300aa-14&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-14</a>. Two
provisions within Part II &mdash; <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a> and <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> &mdash; are central to the
issues presented in this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a>, Congress stipulated that any claimant "qualified" to
bring a claim in Vaccine Court must do so in advance of bringing a civil
suit. 42 U.S.C. &sect; 300aa-ll(a)(2)(A).<a HREF="#fn500" name="fnref_fn500">[fn5]</a> The Act specifies that a qualified
claimant is "any person who has sustained a vaccine-related injury" after
"receiv[ing] a vaccine set forth in the Vaccine Injury Table." &sect;
300aa-ll(b)-(c). If a person is not qualified to file a petition for
compensation under the Program, then this subsection's exhaustion
requirement does not apply. &sect; 300aa-11(a)(9).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, if the person who sustained the vaccine-related injury is a
minor, disabled or deceased, the Act permits that person's parent or legal
representative <span CLASS="page_no" data-cite="2012 bl 244444 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> to file for compensation on behalf of the injured person's
estate. &sect; 300aa-l 1(b)(1)(A). A parent or legal representative may not,
however, file in Vaccine Court for compensation of his or her own individual
damages. <i>See</i> &sect; 300aa-15(d)(2) ("Compensation awarded under the Program may
not include . . . compensation for other than the health, education, or
welfare of <i>the person who suffered the vaccine-related injury</i> with respect
to which the compensation is paid.") (emphasis added). Thus, although we
have never had an occasion to rule on the question, our sister courts have
consistently held that Section 11`s exhaustion requirement does not apply to
a parent's claim for his or her individual injuries. <i>See, e.g., Moss v.</i>
<i>Merck &amp; Co.</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XFPGL4?jcsearch=381%20f%203d%20501&amp;summary=yes#jcite">381 F.3d 501</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XFPGL4?jcsearch=381%20f%203d%20501&amp;summary=yes#jcite">505-06</a> (5th Cir.2004); <i>Schafer</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">20 F.3d at 5-7</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> of the Vaccine Act meanwhile provides vaccine manufacturers
"significant tort-liability protections," <i>Bruesewitz</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1074</a>, by
eliminating liability for injuries from "unavoidable side effects,"
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(1)&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-22</a>(b)(1); eliminating liability for not providing direct
warnings to a claimant, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(c)&amp;summary=yes#jcite">&sect; 300aa-22(c)</a>; and
<span CLASS="page_no" data-cite="697 f 3d 1084" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1084" data-primary-citation="697 F.3d 1080">[*1084]</span> 
imposing a presumption that a manufacturer provided proper directions and
warnings if the manufacturer complied with FDA requirements, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(2)&amp;summary=yes#jcite">&sect;
300aa-22(b)(2)</a>.<a HREF="#fn600" name="fnref_fn600">[fn6]</a> In this way, the Act sets up a quid pro quo: easier and
more certain compensation in exchange for limited remedies within the
traditional tort system. <i>See</i>, e.g., <i>Bruesewitz</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1080</a> ("[T]he
Act's structural <i>quid pro quo</i> leads to the same conclusion: The vaccine
manufacturers fund from their sales an informal, efficient compensation
program for vaccine injuries; in exchange they avoid costly tort litigation
and the occasional disproportionate jury verdict.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Putting these two provisions together, Plaintiffs argue that, because
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a> of the Vaccine Act renders them ineligible for compensation
through the Vaccine Court, no other part of the Act, and particularly not
Section 22's tort-liability limitations, should apply to their claims in
state court. We disagree. The exhaustion requirement in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a> is only a
subsection of Congress's larger statutory scheme to ensure that vaccine
manufacturers have an affordable and predictable way of handling injured
parties' compensation claims. Though parents are not bound by Section ll's
exhaustion requirement, they are not free from the Act's tort liability
limitations. Regardless of whether a plaintiff is the vaccine-recipient or
the parent of one, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> expressly preempts design-defect claims
seeking compensation for injury or death caused by a vaccine's unavoidable
side effects. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)&amp;summary=yes#jcite">&sect; 300aa-22(b)</a>. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> expressly preempts tort suits based
"solely" on the manufacturer's failure to provide direct warnings to the
injured party. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(c)&amp;summary=yes#jcite">&sect; 300aa-22(c)</a>. In reaching these conclusions, we do not
suggest that the Act otherwise forecloses a parent's state law claims.
<span CLASS="page_no" data-cite="697 f 3d 1085" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1085" data-primary-citation="697 F.3d 1080">[*1085]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">

</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  B
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Preemption law begins with the presumption that Congress does not "intend
to displace state law." <i>Maryland v. Louisiana</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CA4A?jcsearch=451%20us%20725&amp;summary=yes#jcite">451 U.S. 725</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CA4A?jcsearch=451%20us%20725&amp;summary=yes#jcite">746</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=101%20supreme%20court%202114&amp;summary=yes#jcite">101 S.Ct. 2114</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CA4A?jcsearch=68%20l%20ed%202d%20576&amp;summary=yes#jcite">68 L.Ed.2d 576</a> (1981). State action may nonetheless be
"foreclosed by express language in a congressional enactment, by implication
from the depth and breadth of a congressional <span CLASS="page_no" data-cite="2012 bl 244444 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> scheme that occupies the
legislative field, or by implication because of a conflict with a
congressional enactment." <i>Lorillard Tobacco v. Reilly</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X6CB47?jcsearch=533%20us%20525&amp;summary=yes#jcite">533 U.S. 525</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X6CB47?jcsearch=533%20us%20525&amp;summary=yes#jcite">541</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X6CB47?jcsearch=121%20supreme%20court%202404&amp;summary=yes#jcite">121 S.Ct. 2404</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X6CB47?jcsearch=150%20l%20ed%202d%20532&amp;summary=yes#jcite">150 L.Ed.2d 532</a> (2001) (internal citations omitted). Thus,
when construing an express preemption clause, a reviewing court must
necessarily begin by examining the clause's "plain wording," as this
"necessarily contains the best evidence of Congress' preemptive intent."
<i>Sprietsma v. Mercury Marine</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XF7BIM?jcsearch=537%20us%2051&amp;summary=yes#jcite">537 U.S. 51</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XF7BIM?jcsearch=537%20us%2051&amp;summary=yes#jcite">62-63</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=123%20supreme%20court%20518&amp;summary=yes#jcite">123 S.Ct. 518</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XF7BIM?jcsearch=154%20l%20ed%202d%20466&amp;summary=yes#jcite">154 L.Ed.2d 466</a> (2002). "We must not be guided by a single sentence or
member of a sentence, but look to the provisions of the whole law, and to
its object and policy." <i>Pilot Life Ins. Co. v. Dedeaux</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X2NU1S?jcsearch=481%20us%2041&amp;summary=yes#jcite">481 U.S. 41</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X2NU1S?jcsearch=481%20us%2041&amp;summary=yes#jcite">51</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X2NU1S?jcsearch=107%20supreme%20court%201549&amp;summary=yes#jcite">107 S.Ct. 1549</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X2NU1S?jcsearch=95%20l%20ed%202d%2039&amp;summary=yes#jcite">95 L.Ed.2d 39</a> (1987); <i>see also Freightliner Corp. v. Myrick</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CCNC?jcsearch=514%20us%20280&amp;summary=yes#jcite">514 U.S. 280</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CCNC?jcsearch=514%20us%20280&amp;summary=yes#jcite">288</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=115%20supreme%20court%201483&amp;summary=yes#jcite">115 S.Ct. 1483</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CCNC?jcsearch=131%20l%20ed%202d%20385&amp;summary=yes#jcite">131 L.Ed.2d 385</a> (1995) ("The fact that an
express definition of the pre-emptive reach of a statute`implies' &mdash; <i>i.e.</i>,
supports a reasonable inference &mdash; that Congress did not in-tend to preempt
other matters does not mean that the express clause entirely fore-closes any
possibility of implied preemption.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Congress included several clauses in Section 22 that inform our preemption
de-termination. First, in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(a)&amp;summary=yes#jcite">Section 22(a)</a>, the Act establishes a default that
traditional state tort remedies remain except in several enumerated
instances, including as provided for in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)&amp;summary=yes#jcite">subsection (b)</a>.
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(a)&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-22</a>(a) ("Except as provided in sub-sections (b), (c), and
(e) of this section State law shall apply to a civil action brought for
damages for a vaccine-related injury or death."). Subsection (b)(1), in
turn, declares that manufacturers shall not be liable for injuries caused by
"side effects that were unavoidable even though the vaccine . . . was
accompanied by proper directions and warnings." And subsection (b)(2) states
that proper directions and warnings will be presumed when the manufacturer
"complied in all material respects with all requirements under the Federal
Food, Drug, and Cosmetic Act. . . ." To rebut this presumption, the Act
requires a plaintiff to show that the manufacturer had (1) engaged in
conduct that would subject it to punitive damages under the Vaccine Act; or
(2) failed to exercise due care. &sect; 300aa-22(b)(2)(A)-(B).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Pursuant to subsection (c), manufacturers are generally immunized from
liability for failure to warn if they have complied with regulatory
requirements and have given the warning to the healthcare professional, the
vaccine recipient, or the vaccine recipient's legal representative. &sect;
300aa-22(c); <i>see also Bruesewitz</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1074</a> n. 25 ("[I]mmunity does
not apply if the plaintiff establishes by clear and convincing evidence that
the manufacturer was negligent, or was guilty of fraud, intentional and
wrongful withholding of in-formation, or other unlawful activity."). Finally
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(e)&amp;summary=yes#jcite">subsection (e)</a> prohibits any state law that is <i>more restrictive</i> than the
Vaccine Act. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(e)&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-22</a>(e) ("No State may establish or enforce a
law which prohibits an individual from bringing a civil action against a
vaccine manufacturer for damages for a vaccine-related injury or death if
such civil action is not barred by this part.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The text of these clauses indicates that Congress expressly intended to
prohibit states from regulating large aspects of tort
<span CLASS="page_no" data-cite="697 f 3d 1086" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1086" data-primary-citation="697 F.3d 1080">[*1086]</span> 
suits against vaccine manufacturers. The Third Circuit <span CLASS="page_no" data-cite="2012 bl 244444 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> explained the
potential scope of this preemption provision: although "stating that`no
state shall pass laws with the following exceptions' may well be broader
than a provision stating`state law applies with the following exceptions'. .
. . [,] the breadth of a provision does not alter the import of the
underlying language, and here that language conveys a clear intent to
override state law civil action claims in particular, defined
circumstances." <i>Bruesewitz v. Wyeth Inc.</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1AR7UE003?jcsearch=561%20f%203d%20233&amp;summary=yes#jcite">561 F.3d 233</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1AR7UE003?jcsearch=561%20f%203d%20233&amp;summary=yes#jcite">243</a> (3d Cir.2009),
<i>aff'd</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1068</a>; <i>see also </i><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1AR7UE003?jcsearch=561%20F.3d%20233&amp;summary=yes#jcite">id. at 242-43</a> (comparing language in
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> of Vaccine Act to analogous express preemption language in
Federal Cigarette Labeling Act and Advertising Act); <i>see, e.g., Lorillard</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X6CB47?jcsearch=533%20us%20525&amp;summary=yes#jcite">533 U.S. at 541</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X6CB47?jcsearch=121%20supreme%20court%202404&amp;summary=yes#jcite">121 S.Ct. 2404</a>; <i>CSX Transp., Inc. v. Easterwood</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CC9A?jcsearch=507%20us%20658&amp;summary=yes#jcite">507 U.S. 658</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CC9A?jcsearch=507%20us%20658&amp;summary=yes#jcite">662</a> n. 2, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=113%20supreme%20court%201732&amp;summary=yes#jcite">113 S.Ct. 1732</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CC9A?jcsearch=123%20l%20ed%202d%20387&amp;summary=yes#jcite">123 L.Ed.2d 387</a> (1993).<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In its recent decision affirming the Third Circuit's reasoning in
<i>Bruesewitz</i>, the Supreme Court elaborated:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      The "even though" clause [in Section 22(b)(1)]. . . . delineates
    the preventative measures that a vaccine manufacturer must have
    taken for a side-effect to be considered "unavoidable" under the
    statute. Provided that there was proper manufacture and warning, any
    remaining side effects, including those resulting from design
    defects, are deemed to have been unavoidable. State-law
    design-defect claims are therefore preempted.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1075</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Bruesewitz</i>, the Supreme Court also discussed the interplay between
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(2)&amp;summary=yes#jcite">subsections (b)(2)</a> and <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(1)&amp;summary=yes#jcite">(b)(1)</a>:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      The structure of the [Vaccine Act] and of vaccine regulation in
    general reinforces what the text of <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(1)&amp;summary=yes#jcite">&sect; 300aa-22(b)(1)</a> suggests. A
    vaccine's license spells out the manufacturing method that must be
    followed and the directions and warnings that must accompany the
    product. Manufacturers ordinarily must obtain the Food and Drug
    Administration's (FDA) approval before modifying either. Deviations
    from the license thus provide objective evidence of manufacturing
    defects or inadequate warnings. Further objective evidence comes
    from the FDA's regulations &mdash; more than 90 of them &mdash; that pervasively
    regulate the manufacturing process, down to the requirements for
    plumbing and ventilation systems at each manufacturing facility.
    Material non-compliance with any one of them, or with any other FDA
    regulation, could cost the manufacturer its regulatory-compliance
    defense.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20S.%20Ct.%201068&amp;summary=yes#jcite">Id. at 1078-79</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Plaintiffs argue that the express preemption discussed in <i>Bruesewitz</i> does
not apply to their case because <i>Bruesewitz</i> involved a claim brought on
behalf of an injured minor child. In such situations, Plaintiffs do not
disagree that <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> would expressly limit some claims for compensation.
But, where as here, a plaintiff could not have first filed in Vaccine Court
for compensation of individual injuries, Plaintiffs claim Section 22's tort
suit limitations are inapplicable. Plaintiffs contend this construction is
supported by the fact
<span CLASS="page_no" data-cite="697 f 3d 1087" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1087" data-primary-citation="697 F.3d 1080">[*1087]</span> 
that Congress did not discuss claims by parents for individual damages in
either the Vaccine Act or the Act's legislative history.<a HREF="#fn800" name="fnref_fn800">[fn8]</a><i>See Schafer</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">20 F.3d at 6</a> (discussing parents' claims in context of legislative history).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We disagree with Plaintiffs' cramped interpretation of the Vaccine Act.
Given <span CLASS="page_no" data-cite="2012 bl 244444 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> the structure and broad purpose of the Act as a whole, it is most
reasonable to apply <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> to all design defect and failure to warn
claims arising out of a vaccine-related injury or death, not just those that
could have first been brought in the Vaccine Court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, Part II of the Vaccine Act, in which <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Sections 11</a> and <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">22</a> appear, is
much broader than Plaintiffs would have us construe it. Part II not only
establishes the vaccine compensation program and Vaccine Table, but it also
outlines the duties of the Secretary of the Department of Health along with
the responsibilities and liability of vaccine manufacturers. Moreover, Part
II provides any citizen &mdash; regardless of whether that person was directly or
indirectly harmed by a vaccine-related injury &mdash; with a cause of action
"against the Secretary where there is alleged a failure of the Secretary to
perform any act or duty under [Part II of the Act]."
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9FK003?jcsearch=42%20U.S.C.%20%20300aa-31(a)&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-31</a>(a).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The structure of <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a> further demonstrates that the Act is meant to
apply broadly. As subsection (a)(9) in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11(a)(9)&amp;summary=yes#jcite">Section 11</a> explains, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a>
"applies only to a person who has sustained a vaccine-related injury or
death and who is qualified to file a petition[.]" &sect; 300aa-ll(a)(9). While
this provision makes clear that the subsection's exhaustion requirements
apply only to those who personally suffered a vaccine-related injury or
death, the provision implies that other sections throughout the Act apply to
all types of potential plaintiffs. Section 22, by comparison, applies to any
"civil action for damages arising from a vaccine-related injury." &sect;
300aa-22(b). Critically, it does not contain a limiting provision equivalent
to the one in Section 11. Thus, Congress's inclusion of the restriction in
Section 11 &mdash; specifically its mention that the bar applies only to that
"subsection" &mdash; coupled with the lack of such a restriction in Section 22
strongly suggest that Congress did not intend for us to apply the Act's tort
suit limitations in the narrow manner urged by Plaintiffs. <i>See Paul Revere</i>
<i>Ins. Group v. United States</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X17J966003?jcsearch=500%20f%203d%20957&amp;summary=yes#jcite">500 F.3d 957</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X17J966003?jcsearch=500%20f%203d%20957&amp;summary=yes#jcite">962</a> (9th Cir.2007) ("It
<span CLASS="page_no" data-cite="697 f 3d 1088" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1088" data-primary-citation="697 F.3d 1080">[*1088]</span> 
is generally presumed that Congress acts intentionally and purposely when it
includes particular language in one section of a statute but omits it in
another.") (internal quotation marks and citations omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F6003?jcsearch=42%20U.S.C.%20%20300aa-23&amp;summary=yes#jcite">Section 23</a>, entitled "Trial," confirms this interpretation. In particular,
the section sets forth three stages &mdash; a liability phase, a compensatory
damages phase, and a punitive damages phase &mdash; by which a civil action "not
barred by <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11(a)(2)&amp;summary=yes#jcite">section 300aa-11(a)</a>(2) of th[e Vaccine Act] shall be tried." <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F6003?jcsearch=42%20U.S.C.%20%20300aa-23&amp;summary=yes#jcite">&sect;
300aa-23</a>. By using this language to qualify the types of cases which may
proceed to trial, Congress opted for a framework inclusive of all civil
actions not otherwise barred by Section 11's exhaustion requirement. Indeed,
only applying the trifurcated scheme to lawsuits filed by injured
vaccine-recipients, and not to their parents, creates a convoluted trial and
liability scenario because the child's case would be subject to the
trifurcation, while the parental claim would presumably proceed in a
traditional single-phased manner. <span CLASS="page_no" data-cite="2012 bl 244444 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> Under that scenario, the jury would apply
the Section 22(b) defenses to the child's claims, but would apply a
different set of state legal rules to the parental claims. This
interpretation would thus require us to assume that Congress gave greater
rights to family members of those injured by vaccines than it did to the
injured vaccine-recipients themselves. Given that the Act's main purpose is
to maintain the nation's vaccine supply while compensating the victims of
vaccine-related injuries, this assumption makes no sense.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, if we were to conclude that the parents of those suffering a
vaccine-related injury could bring design defect and failure to warn claims
outside of Section 22's limitations, we would be acting contrary to the
statute's central purpose of managing vaccine manufacturers' liability
because our construction would do little to protect the vaccine
manufacturers from suit. <i>Cf. Bruesewitz</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F0FHE003?jcsearch=131%20supreme%20court%201068&amp;summary=yes#jcite">131 S.Ct. at 1075</a> ("If a
manufacturer could be held liable for failure to use a different design, the
word`unavoidable' would do no work. A side effect of a vaccine could <i>always</i>
have been avoidable by use of a differently designed vaccine not containing
the harmful element. The language of the provision thus suggests that the
<i>design</i> of the vaccine is a given, not subject to question in the tort
action.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, in several cases where parent-plaintiffs have filed civil actions
for injuries allegedly caused by vaccines and have sought recovery
individually and on behalf of child-plaintiffs, courts have applied Section
22 without distinguishing between the claims. Most notably, this scenario
played out in <i>American Home Products Corp. v. Ferrari</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=284%20georgia%20384&amp;summary=yes#jcite">284 Ga. 384</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X19NSRA003?jcsearch=668%20south%20eastern%202d%20236&amp;summary=yes#jcite">668 S.E.2d 236</a> (2008), <i>vacated</i>, <cite>___ U.S. ___</cite>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F18LC003?jcsearch=131%20supreme%20court%201567&amp;summary=yes#jcite">131 S.Ct. 1567</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=179%20l%20ed%202d%20471&amp;summary=yes#jcite">179 L.Ed.2d 471</a> (2011), <i>remanded to</i><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1FF7LE003?jcsearch=289%20georgia%20184&amp;summary=yes#jcite">289 Ga. 184</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1FF7LE003?jcsearch=710%20south%20eastern%202d%20771&amp;summary=yes#jcite">710 S.E.2d 771</a> (2011).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Ferrari</i>, two parents, individually and on behalf of their son, sued
various vaccine manufacturers alleging that mercury in a vaccine
preservative had caused the child neurological damage. The Ferraris'
complaint also alleged several separate state law claims for their own loss
of services and emotional distress. In reviewing these claims, the district
court held that <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> preempted the alleged design defect claims,
regardless of whether the parents could have first filed their suit in
Vaccine Court. The Georgia appellate courts reversed. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X19NSRA003?jcsearch=668%20south%20eastern%202d%20236&amp;summary=yes#jcite">668 S.E.2d at 237</a>. But
then United States Supreme Court vacated the Georgia courts' judgment,
making no mention of the difference between the claims of the parents and of
the vaccine recipient. <i>See</i><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1F18LC003?jcsearch=131%20supreme%20court%201567&amp;summary=yes#jcite">131 S.Ct. at 1567</a>. On remand, the Georgia courts
did not readily address this issue either. <i>See</i><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1FF7LE003?jcsearch=710%20south%20eastern%202d%20771&amp;summary=yes#jcite">710 S.E.2d at 772</a>. In
interpreting <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a>, it is
<span CLASS="page_no" data-cite="697 f 3d 1089" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1089" data-primary-citation="697 F.3d 1080">[*1089]</span> 
thus telling that the <i>Ferrari</i> Courts treated the claims of the parents and
the claims of the vaccine recipient as equally limited. <i>See also Sykes</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X16KA84003?jcsearch=484%20f%20supp%202d%20289&amp;summary=yes#jcite">484 F.Supp.2d at 299-301</a> (Section 22 barred recovery for alleged design
defect and failure to warn in action filed by parents "individually and as
parents of Wesley Sykes"); <i>Militrano v. Lederle Labs.</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=26%20new%20york%20appellate%20div%203d%20475&amp;summary=yes#jcite">26 A.D.3d 475</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X149306003?jcsearch=810%20new%20york%20supplement%202d%20506&amp;summary=yes#jcite">810 N.Y.S.2d 506</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X149306003?jcsearch=810%20new%20york%20supplement%202d%20506&amp;summary=yes#jcite">506</a> (2006) (<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> barred recovery for "the
plaintiffs" design defect and failure to warn claims based on immunizations
administered to one "infant plaintiff); <i>Wright v. Aventis <span CLASS="page_no" data-cite="2012 bl 244444 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> Pasteur, Inc.</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1ER060003?jcsearch=14%20atlantic%203d%20850&amp;summary=yes#jcite">14 A.3d 850</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1ER060003?jcsearch=14%20atlantic%203d%20850&amp;summary=yes#jcite">852</a> (Pa.Super.Ct.2011) (pursuant to <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a>, no recovery for
allegedly defective design or warnings in products liability action filed by
plaintiffs "Jacqueline and Howard Wright in their own right, and as parents
and natural guardians of Jared Wright, a minor child"), <i>vacated</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1GSVL8003?jcsearch=33%20atlantic%203d%201262&amp;summary=yes#jcite">33 A.3d 1262</a> (Pa.2011); <i>Blackmon</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XF7FI5?jcsearch=328%20f%20supp%202d%20659&amp;summary=yes#jcite">328 F.Supp.2d at 662-66</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We recognize that a parent's loss of a child is an injury distinct from
the harm the child himself suffered. But despite Plaintiffs' protests to the
contrary, applying <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> to their claims does not leave them without a
remedy for their injuries. Plaintiffs alleged eight claims plus a claim for
punitive damages in their state wrongful death action. Application of
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> affects only two of these claims &mdash; the strict products liability
and negligence claims to the extent that they were based upon allegations of
design defect and failure to warn. Therefore six of Plaintiffs' claims
remain unaffected by the Act and each of these provide a possible remedy to
the injuries that they suffered as a result of Jacob's illness and death.
Accordingly, our conclusion is in keeping with the strong presumption that
Congress does not, "without comment, remove all means of judicial recourse
for those injured by illegal conduct." <i>Silkwood v. Kerr-McGee Corp.</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CAOV?jcsearch=464%20us%20238&amp;summary=yes#jcite">464 U.S. 238</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CAOV?jcsearch=464%20us%20238&amp;summary=yes#jcite">251</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/1?citation=104%20supreme%20court%20615&amp;summary=yes#jcite">104 S.Ct. 615</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X5CAOV?jcsearch=78%20l%20ed%202d%20443&amp;summary=yes#jcite">78 L.Ed.2d 443</a> (1984); <i>Cf. Schafer</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">20 F.3d at 6</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  C
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having concluded that <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> generally applies to limit tort liability
in a parent's claim for individual injuries, we must determine the extent to
which it alters Plaintiffs' lawsuit here. Said another way, we now consider
if Plaintiffs' suit is a "civil action for damages arising from a
vaccine-related injury or death associated with the administration of a
vaccine," and thus limited by the Act. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(1)&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-22</a>(b)(1). We
conclude that the Plaintiffs' suit is so limited.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, the Act defines the term "vaccine-related injury or death" as "an
illness, injury, condition, or death associated with one or more of the
vaccines set forth in the Vaccine Injury Table. . . ." <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9FO003?jcsearch=42%20U.S.C.%20%20300aa-33(5)&amp;summary=yes#jcite">&sect; 300aa-33(5)</a>. Here,
the complaint alleges "physical and emotional injuries," and that
"plaintiffs were injured in their bodies and their spirit. . . ."
Furthermore, recovery under the Nevada wrongful death statute is for an
"injury." <i>See Moyer v. United States</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X2G247?jcsearch=593%20f%20supp%20145&amp;summary=yes#jcite">593 F.Supp. 145</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X2G247?jcsearch=593%20f%20supp%20145&amp;summary=yes#jcite">146</a> (D.Nev.1984)
("The Nevada wrongful death statute, NRS <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XJ696U003?jcsearch=Nev.%20Rev.%20Stat.%20%2041.085&amp;summary=yes#jcite">41.085</a>, designates the only types
of injury for which pecuniary damages may be recovered in a wrongful death
action."). Second, the injuries are "associated with a vaccination." The
complaint alleges that the family suffered injuries "as a direct and
proximate result" of Jacob's vaccination. Finally, there is no debate that
the M-M-R II vaccine is listed in the Vaccine Injury Table.
<i>See</i>42 C.F.R. &sect; 100.3.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  III
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For these reasons, there is no cause to disturb the district court's
application of <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> to Plaintiffs' state law products liability claims
of design defect and failure
<span CLASS="page_no" data-cite="697 f 3d 1090" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1090" data-primary-citation="697 F.3d 1080">[*1090]</span> 
to warn. Nor was the district court's grant of summary judgment in favor of
Merck error. During the proceedings below, Merck produced evidence that it
had complied with all regulatory requirements related to M-M-R II. But
Plaintiffs failed to submit evidence sufficient to show that <span CLASS="page_no" data-cite="2012 bl 244444 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> the vaccine had
not been properly prepared or that it had not been accompanied by proper
directions and warnings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Plaintiffs do not challenge on appeal the district court's resolution of
the state law-claims that the district court held were not preempted by the
National Childhood Vaccine Injury Compensation Act.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>AFFIRMED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> M-M-R II, the Measles, Mumps, and Rubella, Virus Vaccine Live, was
approved by the Food and Drug Administration ("FDA") in 1978 for
distribution in the United States. The vaccine has led to more than a
ninety-nine percent decrease in those diseases since its introduction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The parties disagree about whether the vaccine caused Jacob's death,
but causation was not at issue in the district court's summary judgment
ruling.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> As is relevant, Nevada's Wrongful Death Statute states:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
When the death of any person, whether or not a minor, is caused by the
wrongful act or neglect of another, the heirs of the decedent . . . may each
maintain an action for damages against the person who caused the death. . .
. The heirs may prove their respective damages in the action . . . and the
court or jury may award each person pecuniary damages for the person's grief
or sorrow, loss of probable support, companionship, society, comfort and
consortium, and damages for pain, suffering or disfigurement of the
decedent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Nev.Rev.Stat. &sect; <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XJ696U003?jcsearch=Nev.%20Rev.%20Stat.%20%2041.085(2)&amp;summary=yes#jcite">41.085</a>(2)-<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XJ696U003?jcsearch=Nev.%20Rev.%20Stat.%20%2041.085(4)&amp;summary=yes#jcite">(4)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> Specifically, a claimant may file a petition for compensation with a
specially constituted "Vaccine Court," operating under the United States
Court of Federal Claims. 42 U.S.C. &sect; 300aa-ll, 300aa-12. In almost all
circumstances, a special master makes a decision on the claimant's petition
within 240 days. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EG003?jcsearch=42%20U.S.C.%20%20300aa-12(d)(3)&amp;summary=yes#jcite">&sect; 300aa-12(d)(3)</a>. The Court of Federal Claims then reviews
any objections to the special master's decision and enters final judgment
within 120 days. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EG003?jcsearch=42%20U.S.C.%20%20300aa-12(e)&amp;summary=yes#jcite">&sect; 300aa-12(e)</a>. This informal adjudication relies on the
Act's "Vaccine Injury Table," which describes the side effects associated
with each vaccine and provides a timetable as to when those effects should
manifest themselves. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EK003?jcsearch=42%20U.S.C.%20%20300aa-14(a)&amp;summary=yes#jcite">&sect; 300aa-14(a)</a>; 42 C.F.R. &sect; 100.3 (current Vaccine
Injury Table). Unlike in tort suits, a claimant whose injuries fall within
the Table does not need to show causation or fault; rather the claimant need
only show by a preponderance of the evidence that he received a listed
vaccine and then suffered certain symptoms within a defined period of time.
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EI003?jcsearch=42%20U.S.C.%20%20300aa-13&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-13</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EK003?jcsearch=42%20U.S.C.%20%20300aa-14&amp;summary=yes#jcite">300aa-14</a>. Following the adjudication, a claimant may
either accept the court's judgment and forego a traditional tort suit for
damages, or reject the judgment and seek tort relief from the vaccine
manufacturer. <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F2003?jcsearch=42%20U.S.C.%20%20300aa-21(a)&amp;summary=yes#jcite">&sect; 300aa-21(a)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> In relevant part, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11(a)(2)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 300aa-11</a>(a)(2)(A) provides:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
No person may bring a civil action for damages . . . against a vaccine
administrator or manufacturer in a State or Federal court for damages
arising from a vaccine-related injury or death associated with the
administration of a vaccine . . . and no such court may award damages . . .
for such a vaccine-related injury or death, unless a petition has been
filed, in accordance with <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EO003?jcsearch=42%20U.S.C.%20%20300aa-16&amp;summary=yes#jcite">section 300aa-16</a> of this title, for compensation
under the Program for such injury or death[.]
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> In relevant part, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> states:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(a) General Rule
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Except as provided in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)&amp;summary=yes#jcite">subsections (b)</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(c)&amp;summary=yes#jcite">(c)</a>, and <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(e)&amp;summary=yes#jcite">(e)</a> of this section State
law shall apply to a civil action brought for damages for a vaccine-related
injury or death.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(b) Unavoidable adverse side effects; warnings
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(1) No vaccine manufacturer shall be liable in a civil action for damages
arising from a vaccine-related injury or death associated with the
administration of a vaccine after October I, 1988, if the injury or death
resulted from side effects that were unavoidable even though the vaccine was
properly prepared and was accompanied by proper directions and warnings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(2) For purposes of <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)(1)&amp;summary=yes#jcite">paragraph (1)</a>, a vaccine shall be presumed to be
accompanied by proper directions and warnings if the vaccine manufacturer
shows that it complied in all material respects with all requirements under
the Federal Food, Drug, and Cosmetic Act [<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEI5LU003?jcsearch=21%20usc%20301&amp;summary=yes#jcite">21 U.S.C. &sect; 301</a> et seq.] and
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ7S6003?jcsearch=42%20U.S.C.%20%20262&amp;summary=yes#jcite">section 262</a> of this title (including regulations issued under such
provisions) applicable to the vaccine and related to vaccine-related injury
or death for which the civil action was brought unless the plaintiff shows &mdash;
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F6003?jcsearch=42%20U.S.C.%20%20300aa-23(d)(2)(A)&amp;summary=yes#jcite">(A)</a> that the manufacturer engaged in the conduct set forth in subparagraph
(A) or (B) of <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F6003?jcsearch=42%20U.S.C.%20%20300aa-23(d)(2)(B)&amp;summary=yes#jcite">section 300aa-23(d)</a>(2) of this title [fraud or intentional and
wrongful withholding of information from the Secretary during any phase of a
proceeding for approval of the vaccine, after its approval, or other
criminal or illegal activity relating to the safety and effectiveness of
vaccines], or
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(B) by clear and convincing evidence that the manufacturer failed to
exercise due care notwithstanding its compliance with such Act and section
(and regulations issued under such provisions).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(c) Direct warnings
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
No vaccine manufacturer shall be liable in a civil action for damages
arising from a vaccine-related injury or death associated with the
administration of a vaccine after October 1, 1988, solely due to the
manufacturer's failure to provide direct warnings to the injured party (or
the injured party's legal representative) of the potential dangers resulting
from the administration of the vaccine manufactured by the manufacturer.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> Other courts have reached the similar conclusion that design defect
claims are expressly preempted by <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a>. <i>See, e.g., Abbot v. Am.</i>
<i>Cyanamid Co.</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X3I5Q8?jcsearch=844%20f%202d%201108&amp;summary=yes#jcite">844 F.2d 1108</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X3I5Q8?jcsearch=844%20f%202d%201108&amp;summary=yes#jcite">1117</a> (4th Cir.1988) (<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(b)&amp;summary=yes#jcite">Sections 22(b)</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(c)&amp;summary=yes#jcite">(c)</a>, and
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22(e)&amp;summary=yes#jcite">(e)</a> "expressly preempt state law in several respects"); <i>Blackmon v. Am. Home</i>
<i>Prods. Corp.</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XF7FI5?jcsearch=328%20f%20supp%202d%20659&amp;summary=yes#jcite">328 F.Supp.2d 659</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XF7FI5?jcsearch=328%20f%20supp%202d%20659&amp;summary=yes#jcite">662-66</a> (S.D.Tex.2004) (same). Courts have
likewise recognized the Vaccine Act's express limitations on failure to warn
claims. <i>See, e.g., Sykes v. Glaxo-Smith-Kline</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X16KA84003?jcsearch=484%20f%20supp%202d%20289&amp;summary=yes#jcite">484 F.Supp.2d 289</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X16KA84003?jcsearch=484%20f%20supp%202d%20289&amp;summary=yes#jcite">295</a>
(E.D.Pa.2007) ("Vaccine Act clearly bars claims based on a vaccine
manufacturer's failure to provide warnings to an individual who receives its
vaccine.").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> To support their interpretation that <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9F4003?jcsearch=42%20U.S.C.%20%20300aa-22&amp;summary=yes#jcite">Section 22</a> has a narrow reach,
Plaintiffs heavily rely on two cases from our Sister Circuits &mdash; <i>Schafer v.</i>
<i>American Cyanamid Co.</i> and <i>Moss v. Merck &amp; Co.</i> &mdash; which both held that Section
11's exhaustion requirement did not apply to bar parents from filing
directly in state court. <i>See Schafer</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">20 F.3d at 2</a> ("The question before us
in this appeal . . . is whether the Act also bars the family of . . . a
person [injured by a vaccine] from bringing a tort suit to obtain
compensation for their own, related, injuries, in particular, for loss of
companion-ship or consortium. Assuming that state law permits such suits, we
find nothing in the Act that explicitly or implicitly bars them."); <i>Moss</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XFPGL4?jcsearch=381%20f%203d%20501&amp;summary=yes#jcite">381 F.3d at 505</a> ("The program delays the filing of only those tort claims
for which it first provides an alternate source of compensation.").
Plaintiffs cite to numerous district and state court decision for the same
proposition as well. <i>See, e.g., Bertrand v. Aventis Pasteur Labs., Inc., lid</i>
F.Supp.2d 1206, 1214 (D.Ariz.2002); <i>Hobart v. Holt</i>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X19OH4M003?jcsearch=222%20oregon%20appellate%20550&amp;summary=yes#jcite">222 Or.App. 550</a>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X19OH4M003?jcsearch=194%20pacific%203d%20820&amp;summary=yes#jcite">194 P.3d 820</a>, <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X19OH4M003?jcsearch=194%20pacific%203d%20820&amp;summary=yes#jcite">825</a> (2008). But critically, none of the cases cited by
Plaintiffs discuss Section 22's tort liability limitations. <i>Cf. Schafer</i>,
<a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X50BK6?jcsearch=20%20f%203d%201&amp;summary=yes#jcite">20 F.3d at 5</a> ([T]he Act <i>subsection</i> [in <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a>] that creates the tort
action bar says that [the bar] does not apply to this kind of lawsuit.")
(emphasis added). Framed an-other way, these cases interpreted <a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/XEJ9EE003?jcsearch=42%20U.S.C.%20%20300aa-11&amp;summary=yes#jcite">Section 11</a> to
permit parents to file directly in state court. The current case thus picks
up where these other cases left off: it considers the claims that may be
made against a vaccine manufacturer once a parent is actually in court.
</p></div>
<!--BBLS DD 1736096481283-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1IGRMK003/history">Direct History (3)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1IGRMK003/analysis">Case Analysis (1)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1IGRMK003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
1
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Health &amp; Medical</div><div class='facetItemLabel'>Pharmaceutical Manufacturing</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/9ed54d21bd784edb8594de6321310895/document/X1Q6L0BL9N82">08-16557 (9th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Health Law</div><div class='facetItemLabel'>Products Liability</div><div class='facetItemLabel'>Torts</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/9ed54d21bd784edb8594de6321310895/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "9ed54d21bd784edb8594de6321310895";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY8c7850&previousPageId=&previousActivityInstanceId=ENTITYf92799&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:26:56-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1IGRMK003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYf92799&previousPageId=&previousActivityInstanceId=ENTITYc4a8f9&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:26:55-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1IGRMK003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1IGRMK003";
$('#page_loader').show().spin();
JUDGE_IDS=["1799074"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
